Perinatal Drug Screen Urine with Reflex to Quantitative Confirmation


Abbrev Code:UDS10   
Order Code:LAB3826Order Name:Drug Abuse Scr Perinatal UR W QNT Reflex
Synonyms:Newborn Drug Abuse Screen; Perinatal Drug Screen
Methodology:Initial testing by immunoassay (IA), confirmation of positive by mass spectrometry (MS)
CPT Codes: 80307 x1
Test Includes:Amphetamines, Barbiturates, Benzodiazepines, Cannabinoid, Cocaine (Metab), Opiates, Oxycodone/Oxymorphone, PCP, Ethyl Glucuronide, Cotinine
Turnaround Time:Specimens are sent to the reference laboratory Mon-Fri; results are reported within 4 days.
Special Instructions:Note: Contains expanded benzodiazepine confirmation upon reflex of positive screen. Opiate confirmation of positive screen includes hydrocodone, hydromorphone, codeine and morphine.
Associated Links:

Urine Collection Procedure, Drugs of Abuse Screen



Collection Instructions

Specimen:Urine, random collection
Optimal Volume:Submit entire collection; analysis requires 3 mL
Container:Plastic leakproof container, sterile


Processing and Shipping

Specimen Processing:Aliquot 30 mL; 3 mL minimum. Store at room temperature.
Shipping Instructions:Ship stat at room temperature.
Stability:Maintain specimen at room temperature. If arrival will extend beyond 7 days, then refrigerate.
Test Performed at or Referral Lab Lab Sendouts  (MedTox/LabCorp)
Referral Lab number:724774


Interpretive

Use:Detect and confirm presence of prescribed and illicit drugs for screening during pregnancy.


Click HERE to Report test errors or omissions.
*If no email program is associated with this computer, please contact:
systemlabguide@fairview.org for TestID: 6258"